When the mouse mammary glands from Selenof KO mice were compared to age-matched wild-type mice, it showed a significant increase in Ki67 and a reduction in p21, the cyclin-dependent kinase inhibitor, consistent with the SELENOF silencing data in human breast cancer cell lines and opposite to the SELENOF induction data. Here, MKI67 is linked to breast cancer.